Atypical Antipsychotics That Cause Drowsiness Besides Quetiapine
Olanzapine is the most sedating atypical antipsychotic besides quetiapine, followed by risperidone, with both medications commonly causing drowsiness as a significant side effect. 1, 2, 3
Sedation Profile of Atypical Antipsychotics
High Sedation Potential
- Olanzapine: Causes significant drowsiness in approximately 53% of patients 3
- Mechanism: Strong histamine H1 receptor and α1-adrenergic receptor antagonism
- Sedation is often dose-dependent (10-20 mg range)
- Particularly sedating when used in PTSD-related sleep disorders 1
Moderate Sedation Potential
- Risperidone: Causes drowsiness in approximately 50% of patients 3, 4
- Demonstrates significant α1-noradrenergic antagonism
- Sedation typically occurs at doses of 1-3 mg/day
- Often used in PTSD-related nightmares due to its sedative properties 1
Lower Sedation Potential
- Aripiprazole: Causes less drowsiness compared to olanzapine and risperidone 4
- Ziprasidone: Moderate somnolence profile 4
- Lurasidone: Lower somnolence potential 4
- Paliperidone: Lower somnolence potential 4
Clinical Considerations When Selecting Sedating Antipsychotics
Time Course of Sedation
- Sedation is often most pronounced during initial treatment and may diminish over time
- For olanzapine, drowsiness typically begins within hours of administration 2
- For risperidone, sedation may be more pronounced with twice-daily dosing 5
Dosing Strategies to Manage Sedation
- Evening dosing: Administering more sedating antipsychotics at bedtime can utilize the sedative effect for sleep benefits
- Slow titration: Starting at lower doses and gradually increasing can help develop tolerance to sedative effects
- Once-daily dosing: When possible, consolidating doses to minimize daytime drowsiness
Risk Factors for Increased Sedation
- Elderly patients
- Concurrent use of other CNS depressants
- Hepatic impairment (reduced drug metabolism)
- Low body weight
Therapeutic Applications of Sedating Properties
Sedating antipsychotics can be beneficial in specific clinical scenarios:
- Agitation and acute psychosis: Sedation can be therapeutic in managing acute agitation 1
- PTSD-related nightmares: Olanzapine and risperidone have shown efficacy in reducing nightmares 1
- Insomnia with psychotic disorders: The sedative effect can help normalize sleep patterns
Adverse Effects Beyond Sedation
When selecting sedating antipsychotics, consider these additional adverse effects:
- Olanzapine: Significant weight gain (51% of patients), metabolic effects 2, 3
- Risperidone: Extrapyramidal symptoms (more common than with olanzapine), hyperprolactinemia 2, 1
- All atypical antipsychotics: Risk of orthostatic hypotension, particularly during initial titration 6
Monitoring Recommendations
When using sedating antipsychotics:
- Assess for excessive daytime drowsiness that may impact functioning
- Monitor for falls, particularly in elderly patients 6
- Evaluate the impact on driving and operating machinery
- Consider dose adjustments if sedation is problematic after 4 weeks (when tolerance should develop) 4
Remember that sedation profiles can vary significantly between individuals, and clinical response should guide medication selection and dosing strategies.